News about "central nervous system "

Italfarmaco, JCR Sign License Deal for Hunter Syndrome Therapy

JCR Pharmaceuticals and Italfarmaco expand their rare disease collaboration with a global license agreement for JR-141.

Central Nervous System | 05/10/2026 | By News Bureau

RPG Life Sciences Subsidiary to Acquire Raghava Life Sciences' API Business for Up to INR 135 Crore

RPG Active Pharma’s latest acquisition expands its manufacturing capacity, API portfolio and regulatory capabilities as part of its buy-and-build strategy.

Central Nervous System | 03/09/2026 | By Akanki |  129

Estrella Doses First Patient in EB103 Dose-Expansion Trial for Relapsed/Refractory B-Cell NHL

Estrella Immunopharma advances its STARLIGHT-1 Phase I/II trial with the first patient dosed in the EB103 dose-expansion cohort, building on promising early efficacy in relapsed/refractory B-cell non-Hodgkin’s lymphoma.

Central Nervous System | 28/07/2026 | By News Bureau

Roche's Fenebrutinib Shows Promise in Third Phase III MS Trial

Roche reported positive Phase III FENhance 1 results, with fenebrutinib reducing relapses by 51 percent in relapsing multiple sclerosis, consistent with prior FENhance 2 and FENtrepid data. The company plans regulatory submissions, positioning fenebrutinib as a potential first-in-class BTK inhibitor for relapsing and primary progressive MS.

Central Nervous System | 02/03/2026 | By News Bureau |  271

Genethon Partners with AskBio on Pompe Gene Therapy

The licensing deal enables AskBio to advance the clinical development of Genethon’s investigational gene therapy for Pompe disease through an industry partnership.

Central Nervous System | 15/01/2026 | By News Bureau |  234

Cipla to Enter Weight Management Segment, Expands Focus on Oncology and CNS Therapies

Cipla is set to enter India’s growing weight management market as part of its broader strategy to expand across emerging therapeutic segments.

Central Nervous System | 14/07/2025 | By Dineshwori |  290

JCR Pharmaceuticals and Modalis to Develop Novel Gene Therapy

The purpose of this joint agreement is to conduct pre-clinical studies for the development of a new gene therapy for the undisclosed CNS disease by applying J-Brain Cargo®, JCR’s proprietary technology.

Central Nervous System | 06/01/2025 | By Aishwarya |  551

AbbVie Announces Acquisition of Aliada Therapeutics

Aliada's lead investigational asset is ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody, which is in development for the treatment of patients with Alzheimer's disease and is currently in a Phase 1 clinical trial.

Central Nervous System | 13/12/2024 | By Aishwarya |  558

AbbVie and Gedeon Richter to Develop Novel Targets for Neuropsychiatric Conditions

This collaboration expands upon the success of nearly two decades of partnership on central nervous system (CNS) projects, including globally launched products such as cariprazine (VRAYLAR / REAGILA) and the discovery of investigational drug candidate ABBV-932 for the treatment of bipolar depression and generalized anxiety disorder.

Central Nervous System | 25/10/2024 | By Aishwarya |  290

Lupin Rolls Out First Generic Version of Oracea

Lupin has unveiled the first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States.

Central Nervous System | 10/04/2024 | By Aishwarya |  708